140 related articles for article (PubMed ID: 37046057)
1. Ocular side effects of Trametinib and Dabrafenib: a case report.
Tarım B; Kılıç M
J Ophthalmic Inflamm Infect; 2023 Apr; 13(1):17. PubMed ID: 37046057
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review.
Yilmaz Tugan B; Ozkan B; Sonmez O
Semin Ophthalmol; 2021 Nov; 36(8):794-799. PubMed ID: 33780309
[No Abstract] [Full Text] [Related]
3. Ocular toxicity due to Trametinib and Dabrafenib.
Sarny S; Neumayer M; Kofler J; El-Shabrawi Y
BMC Ophthalmol; 2017 Aug; 17(1):146. PubMed ID: 28818062
[TBL] [Abstract][Full Text] [Related]
4. Bilateral uveitis and macular edema induced by Nivolumab: a case report.
Theillac C; Straub M; Breton AL; Thomas L; Dalle S
BMC Ophthalmol; 2017 Dec; 17(1):227. PubMed ID: 29195497
[TBL] [Abstract][Full Text] [Related]
5. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
6. Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib.
Draganova D; Kerger J; Caspers L; Willermain F
J Ophthalmic Inflamm Infect; 2015; 5():17. PubMed ID: 26078801
[TBL] [Abstract][Full Text] [Related]
7. Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.
Otsubo M; Kinouchi R; Kamiya T; Yoshida A
J Med Case Rep; 2021 Jul; 15(1):355. PubMed ID: 34284818
[TBL] [Abstract][Full Text] [Related]
8. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.
Markomichelakis NN; Halkiadakis I; Pantelia E; Peponis V; Patelis A; Theodossiadis P; Theodossiadis G
Ophthalmology; 2004 May; 111(5):946-53. PubMed ID: 15121373
[TBL] [Abstract][Full Text] [Related]
9. Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib.
Rueda-Rueda T; Sánchez-Vicente JL; Moruno-Rodríguez A; Molina-Socola FE; Martínez-Borrego AC; López-Herrero F
Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):458-462. PubMed ID: 29580759
[TBL] [Abstract][Full Text] [Related]
10. Resolution of bilateral cystoid macular edema and subfoveal serous retinal detachments after treatment with bortezomib in a patient with "smoldering" multiple myeloma.
Grannis CH; Dewan VN; Wang RC
Retin Cases Brief Rep; 2014; 8(4):348-51. PubMed ID: 25372546
[TBL] [Abstract][Full Text] [Related]
11. Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report.
Kiraly P; Groznik AL; Valentinčič NV; Mekjavić PJ; Urbančič M; Ocvirk J; Mesti T
World J Clin Cases; 2022 Jul; 10(19):6536-6542. PubMed ID: 35979276
[TBL] [Abstract][Full Text] [Related]
12. Clinical findings and outcomes of uveitis associated with multiple sclerosis.
AlBloushi AF; Dheyab AM; Al-Swaina NF; Al-Obailan M; Daif AK; Abu El-Asrar AM
Eur J Ophthalmol; 2021 Mar; 31(2):482-490. PubMed ID: 32019337
[TBL] [Abstract][Full Text] [Related]
13. Assessment of serous macular detachment in eyes with diabetic macular edema by use of spectral-domain optical coherence tomography.
Koleva-Georgieva D; Sivkova N
Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1461-9. PubMed ID: 19547995
[TBL] [Abstract][Full Text] [Related]
14. Anti-interleukin-6 receptor therapy with tocilizumab for refractory pseudophakic cystoid macular edema.
Pham BH; Hien DL; Matsumiya W; Tuong Ngoc TT; Doan HL; Akhavanrezayat A; Yaşar Ç; Nguyen HV; Halim MS; Nguyen QD
Am J Ophthalmol Case Rep; 2020 Dec; 20():100881. PubMed ID: 32875161
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings.
Ozdek SC; Erdinç MA; Gürelik G; Aydin B; Bahçeci U; Hasanreisoğlu B
Ophthalmologica; 2005; 219(2):86-92. PubMed ID: 15802932
[TBL] [Abstract][Full Text] [Related]
16. Serous macular detachment in central retinal vein occlusion.
Ozdemir H; Karacorlu M; Karacorlu S
Retina; 2005; 25(5):561-3. PubMed ID: 16077350
[TBL] [Abstract][Full Text] [Related]
17. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
18. Bilateral uveitis associated with nivolumab therapy for metastatic non-small cell lung cancer.
Dermarkarian CR; Patel NA; Villegas VM; Harbour JW
Am J Ophthalmol Case Rep; 2020 Jun; 18():100691. PubMed ID: 32322748
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of macular edema with optical coherence tomography.
Hee MR; Puliafito CA; Wong C; Duker JS; Reichel E; Rutledge B; Schuman JS; Swanson EA; Fujimoto JG
Arch Ophthalmol; 1995 Aug; 113(8):1019-29. PubMed ID: 7639652
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
